EXALT IP
  • Home
  • What we do
  • Blog
  • Contact
  • Home
  • What we do
  • Blog
  • Contact
Search

The $1.25bn patent

2/10/2022

0 Comments

 
It is very unusual for a single patent to be so valuable, and it is probably only so in the pharmaceutical space.

But how so valuable?
 
When we are talking about a product that uses the patent achieving $7bn sales each year (and projected to earn another $50bn in the next 5 years) then it gets really interesting. This is where the patent attorneys and litigators really earn their crust.

Picture
So Gilead lost to GSK in a 4 year long patent battle, Gilead were found to use GSK’s US patent 8,129,385 in their own HIV treatment.
 
GSK and Gilead agreed a damages settlement of $1.25bn and a running royalty of 3% of sales, likely to generate another $1.5bn before the patent expires in Autumn 2027.
 
A former CEO of GSK once said his patent attorneys were the most valuable players on his team, with a settlement like this it is easy to see why.
​

Ask how patents help your business? Click here
Picture

Helping startups, scaleups, shakeups and CEOs to improve the value of their businesses by using intellectual property to protect ideas, creations, inventions, and competitive advantage.
Protecting #Innovations with #Patents and #Brands with Registered #Trademarks also with Unregistered Trademarks, #DigitalBrand #BrandProtection and #SocialMedia. ​Help with using #Copyright and #TradeSecrets to protect your Software and Business. 

We Can Help You so call +447587885131 for a Confidential and Free Initial Chat or check www.Exaltip.com for more information.    

​

COPYRIGHT PROTECTED © 2019 - 2022 Exalt IP Limited. All rights reserved.
0 Comments



Leave a Reply.

    Author: John Pryor Exalt IP



    View my profile on LinkedIn
    Contact Us
COPYRIGHT PROTECTED DOCUMENT
© 2022 Exalt IP Limited. 
All rights reserved.
Site powered by Weebly. Managed by Looka
  • Home
  • What we do
  • Blog
  • Contact